Anti-Human ITGB2 Recombinant Antibody (Rovelizumab) (CAT#: TAB-044)

Recombinant monoclonal antibody to CD18. Rovelizumab, also known as LeukArrest and Hu23F2G, is a humanized monoclonal antibody which was an experimental immunosuppressive drug. The drug is a monoclonal antibody that suppresses white blood cells which become overly active during shock.

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Mouse
  • Derivation
  • Humanized (from mouse)
  • Type
  • IgG4
  • Specificity
  • Tested positive against native human antigen.
  • Species Reactivity
  • Human
  • Applications
  • Suitable for use in Neut, ELISA, IF, IP, FuncS, FC, IHC and most other immunological methods.
  • Trade name
  • leukarrest
  • CAS
  • 197099-66-4
  • Generic Name
  • Rovelizumab
  • Related Disease
  • Ischemic stroke
This site uses cookies. Find out more about this site’s cookies. GOT IT!